Company: VRCA
Filing Date: 2025-04-22
Form Type: DEF 14A
Source: 0001193125-25-087838
Chunk: 47

Company: Verrica Pharmaceuticals Inc.
Filing Date: 2025-04-22
Form: DEF 14A
Chunk 47
---
 under our 2013 Equity Incentive Plan (the “2013 Plan”) and all of the option awards granted following the completion of our initial public offering were granted under our 2018 Equity Incentive Plan (the “2018 Plan”) unless otherwise noted. |

36

| (2) | The market value amount is calculated based on the closing price of our common stock of $0.70 per share at |

| (3) | The shares of common stock underlying this option vest and become exercisable over a four-year period as to 1/8th of the common stock underlying the option on April 5, 2025 and as to 1/48th of the shares of common stock underlying the option in monthly installments thereafter, subject to the recipient’s continued service through each vesting date. This option was granted under our 2024 Inducement Plan (the “2024 Inducement Plan”). |

| (4) | 50% of the shares of common stock underlying this option vest and become exercisable on April 9, 2025 and the remaining 50% of the shares of common stock underlying this option vest and become exercisable on October 9, 2025, subject to the recipient’s continued service through each vesting date. |

| (5) | The shares of common stock underlying this option vest and become exercisable over a four-year period as to 25% of the common stock underlying the option on March 15, 2025 and as to 75% of the shares of common stock underlying the option in 36 equal monthly installments thereafter, subject to the recipient’s continued service through each vesting date. |

| (6) | The remaining unvested shares of common stock underlying this option vest and become exercisable in 27 equal monthly installments until March 1, 2027, subject to the recipient’s continued service through each vesting date. |

| (7) | The remaining unvested shares of common stock underlying this option vest and become exercisable in 14 equal monthly installments until February 24, 2026, subject to the recipient’s continued service through each vesting date. |

| (8) | The remaining unvested shares of common stock underlying this option vest and become exercisable in 3 equal monthly installments until March 1, 2025, subject to the recipient’s continued service through each vesting date. |

| (9) | These shares represent RSUs